Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease

The discovery of the D3 receptor (D3R) subtypes of dopamine (DA) has generated an understandable increase in interest in the field of neurological diseases, especially Parkinson’s disease (PD). Indeed, although DA replacement therapy with l-DOPA has provided an effective treatment for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chagraoui, Abdeslam, Di Giovanni, Giuseppe, De Deurwaerdère, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961531/
https://www.ncbi.nlm.nih.gov/pubmed/35204744
http://dx.doi.org/10.3390/biom12020243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961531/
https://www.ncbi.nlm.nih.gov/pubmed/35204744
http://dx.doi.org/10.3390/biom12020243

Ejemplares similares